Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"

NCT06901908 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06901908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06901908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
November 1, 2027
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

suspicious for papillary thyroid carcinoma